Zusammenfassung
Trotz intensiver prophylaktischer Maßnahmen nehmen thromboembolische Erkrankungen infolge der Verlängerung der Lebenserwartung, einer Erweiterung der Indikation zu operativen Eingriffen und eines Anstiegs intensiv konservativer Therapiemaßnahmen ständig zu. Die Zahl der Thrombosekranken wächst weiterhin aufgrund der Zunahme schädlicher Verhaltensweisen, wie Übergewicht, mangelndes sportliches Training, vitaminarme Ernährung, Nikotinabusus und ungezielte Hormonmedikation. Daher ist es von großer Bedeutung, sowohl erbliche als auch erworbene Risikofaktoren zu erkennen, mit dem Ziel, ein individuelles Risikoprofil in gewissen Situationen aufzustellen, um eine individuelle Thromboseprophylaxe zu ermöglichen. Die Erkennung des individuellen Risikoprofils ist die Voraussetzung für eine gezielte primäre Prophylaxe.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aderka B, Brown A, Zelikovski A, Pinkhas I (1986) Idiopathic deep vein thrombosis in an apparently healthy patient as a premonitory sign of occult cancer. Cancer 57:1846.
Ben-Tal 0, Zivelin A, Seligsohn U (1989) The relative frequency of hereditary thrombotic disorders among 107 patients with thrombophilia in Israel. Thromb Hwmost 61(1):50.
Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Buller HR, Vandenbroucke JP (1995) Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 346:83–87.
Bounameaux H, Bongard O, Huber O (1992) Epidemiologie und Risikofaktoren der venösen Thromboembolic. Ther Umschau 49/12:799–802.
Boven HH von, Reitsma PH, Rosendaal FR, Bayston TA, Chowdhury V, Bauer KA, Scharrer I, Conard J, Lane DA (1996) Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin Deficiency. Thromb Haemost 75/3:417–421.
Conard J, Horellou MH, Van Dreden P, Samama M (1988) Prevalence of hereditary hypercoagulable states. Xth International Congress on Thrombosis of the Mediterranean League Against Thromboembolic Diseases, Athens.
Conard J, Horellou MH, Van Dreden P, Lecompte T, Samama M (1990) Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women (letter). Thromb Haemost 63:319–320.
Gladson CL, Scharrer I, Hach V, Beck KH, Griffin JH (1988) The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost 59/1:18.
Hach-Wunderle V (1991) Hämostaseologisches Risikoprofil bei der venösen Thrombose. Habilitationsschrift, Universität Frankfurt/Main.
Heijboer H, Brandjes DPM, Buller HR, Sturk A, ten Cate JW (1990) Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 323:1512.
Heijer den M, Blom EIJ, Gerrits WBJ, Rosendaal FR, Elaak HL, Wijermans PW, Bos GMJ (1995) Is hyperhomocysteinaemia a risk factor for current venous thrombosis? Lancet 345:882–885.
Hirsh J, Prins M, Samama M (1994) Approach to the thrombophilic patient for hemostasis and thrombosis: basic principles and clinical practice. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, Lippincott JB (eds) Hemostasis and Thrombosis, 3rd edn. Lippincott, Philadelphia, pp 1543–1561.
Koster T (1995) Deep-vein thrombosis, a population based case-control study (Leiden Thrombophilia Study), Dissertation, Universität Leiden.
Monreal M, Salvador R, Sorliano V, Sabria M (1988) Cancer and deep venous thrombosis. Arch Intern Med 148:485.
Monreal M, LafoxE, Casals A (1991) Occult cancer in patients with deep venous thrombosis. A systemic approach. Cancer 67:541.
Pabinger S(1996) Diagnosis and clinical features of thrombophilia - with special respect to additional risk situation. Ann Hematology(Suppl. 1) 72:23.
Prandoni P, Cattelan AM, Noventa F, Brogini A, Roul A (1990) Risk of subsequent malignant neoplasmas in patients with deep-vein thrombosis (abstract). Fibrinolysis 4 (suppl):54.
Rickles FR, Levine M, Edwards RL (1992) Hemostatic alteration in cancer patients. Cancer and Met Rev 11:237–248.
Spitzer WO, Lewis MA, Heinemann LAJ (1996) Third generation oral contraceptives and risk of venous thrombosis, an international case-control study. BMJ 312:83–88.
Svendsen E, Krawinsky B (1989) Prevalence of pulmonary embolism at necropsy in patients with cancer. J Clin Pathol 42:805–809.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Scharrer, I. (1997). Primäre Prophylaxe unter Berücksichtigung des individuellen Risikoprofils. In: Hach-Wunderle, V., Haas, S. (eds) Thromboembolie-Prophylaxe in der Inneren und operativen Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60569-7_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-60569-7_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61773-0
Online ISBN: 978-3-642-60569-7
eBook Packages: Springer Book Archive